Capvizr
News · All summaries
Healthcare & Life Sciences
AcesoStem Biostrategies
Series A$2.6 million
RoundSeries A
Amount$2.6 million
DateJune 1, 2026
THE DEAL, AT A GLANCE

AcesoStem Biostrategies

From the announcement
Who is involvedBacked by new investors BlissVine Ventures, Seoul Technology Holdings, with participation from other new investors Mira Ventures, Tap Angel PartnersFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedAcesoStem Biostrategies raised $2.6M Series A, announced 2026-06-01From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersAcesoStem Biostrategies' $2.65M Series A is a small, isolated Energy & Climate allocation in the tracked Capvizr market, with the round sitting at the 20th percentile…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

AcesoStem Biostrategies · Financing Record

Explore source-linked visual explanations for AcesoStem Biostrategies. Unsupported claims are withheld while source review continues.

Record 5011 · Recorded date: 2026-06-01

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime